Abstract

Today a number of synthetic antibody libraries of different formats have been created and used for the selection of a large number of recombinant antibodies. One of the determining factors for successful isolation of recombinant antibodies from libraries lies in the quality of the libraries i.e. the number of correctly folded, functional antibodies contained in the library. Here, we describe the construction of a novel, high quality, synthetic single domain antibody library dubbed Predator. The library is based on the HEL4 domain antibody with the addition of recently reported mutations concerning the amino acid composition at positions critical for the folding characteristics and aggregation propensities of domain antibodies. As a unique feature, the CDR3 of the library was designed to mimic the natural human immune response by designating amino acids known to be prevalent in functional antibodies to the diversity in CDR3. CDR randomizations were performed using trinucleotide synthesis to avoid the presence of stop codons. Furthermore a novel cycle free elongation method was used for the conversion of the synthesized single stranded DNA containing the randomized CDRs into double stranded DNA of the library. In addition a modular approach has been adopted for the scaffold in which each CDR region is flanked by unique restrictions sites, allowing easy affinity maturation of selected clones by CDR shuffling. To validate the quality of the library, one round phage display selections were performed on purified antigens and highly complex antigen mixtures such as cultured eukaryotic cells resulting in several specific binders. The further characterization of some of the selected clones, however, indicates a reduction in thermodynamic stability caused by the inclusion the additional mutations to the HEL4 scaffold.

Highlights

  • Recombinant antibody technology relies on the manipulation of genes encoding antibodies outside of the human body

  • The choice of recombinant antibody scaffold most often lies between the fragment antigen binding (Fab), the single-chain variable fragment, or the domain antibody scaffold, all of which have been shown to be suitable for the phage display technique (Figure 1) [1,2,3]

  • As the CDR1 has been shown to be critical for the properties of the HEL4 antibody, randomizations were only made in CDR2 and CDR3

Read more

Summary

Introduction

Recombinant antibody technology relies on the manipulation of genes encoding antibodies outside of the human body. A human domain antibody library using the HEL4 scaffold was counter-selected for aggregation and the CDR regions of the resulting clones were sub-cloned and used for generating a new library with diversity in all three CDR regions. This library is available from Source Bioscience, UK [10]. Further studies of domain antibodies have underscored that the regions governing the aggregation propensity are located in or adjacent to the CDR regions This was shown more detailed in sequence analysis of unselected clones and clones counter selected for aggregation. The CDR2 and CDR3 did, not seem to contribute significantly to the aggregation resistance properties of HEL4 in this study [11]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.